Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Ltd has informed BSE that a meeting of its Board of Directors will be held on Tuesday, 20th May 2025 at 4:00 p.m. The key agenda item is to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended 31st March 2025, along with the Audit Report. Other routine business items as per the circulated agenda will also be transacted. This is a standard advance intimation filed under Regulation 29 of the SEBI (LODR) Regulations, 2015.
No immediate price impact expected from this intimation alone — actual impact will depend on the audited Q4 and FY25 results announced post the meeting on 20th May. Investors should watch for revenue, profitability, margins, and any audit qualifications or emphasis-of-matter notes in the financial results.